ZIG
CRMD icon

Zullo Investment Group’s CorMedix CRMD Stock Holding History

Zullo Investment Group’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,000
Closed -$4.22K – 251
2022
Q4 		$4.22K Hold
1,000
– – ﹤0.01% 622
2022
Q3 		$3K Hold
1,000
– – ﹤0.01% 645
2022
Q2 		$4K Hold
1,000
– – ﹤0.01% 645
2022
Q1 		$5K Buy
1,000
+150
+18% +$687 ﹤0.01% 645
2021
Q4 		$4K Buy
+850
New +$4.22K ﹤0.01% 681

Other funds holding CRMD

Nomura Holdings
Nomura Holdings Tokyo, Japan $85.4B AUM 91.09% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SC
Spinnaker Capital Boston, Massachusetts $1.08M AUM 45.28% 1-Year Est. Return

Zullo Investment Group's CRMD Position: Q1 2023 in Review

Zullo Investment Group sold out of CorMedix (CRMD) in Q1 2023, closing a stake of 1,000 shares — an estimated $4.22K sold.

Zullo Investment Group first reported a position in CRMD in Q4 2021 and held it in 5 quarters. The position peaked at $5K in Q1 2022. 65 funds tracked by Wall St. Rank hold CRMD as of Q1 2023.

  • Zullo Investment Group reported no remaining CorMedix position as of Q1 2023 after selling out during the quarter.
  • Zullo Investment Group sold 1,000 CorMedix shares in Q1 2023, an estimated $4.22K.
  • Zullo Investment Group first reported a position in CorMedix in Q4 2021 and held it in 5 quarters.
  • Zullo Investment Group's CorMedix position peaked at $5K in Q1 2022.
  • 65 funds tracked by Wall St. Rank held CorMedix as of Q1 2023.

Based on Zullo Investment Group's 13F filing for Q1 2023, filed 25 Apr 2023.